FDA Approves Merck ’s New Drug For A Rare Lung Disease

The pharmaceutical giant ’s new treatment, sotatercept, showed significant benefits for the thousands of patients suffering from pulmonary arterial hypertension in clinical trials.

Source: Forbes.com Healthcare News - March 26, 2024 Category: Pharmaceuticals Authors: Alex Knapp, Forbes Staff Tags: Science /science Innovation /innovation Healthcare /healthcare Editors' Pick editors-pick Premium Content premiumcontent technology alexknappblog Source Type: news